iiinova — where your digital self keeps evolving

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 02/10/2026

We are honoring Dr. Areej R. El-Jawahri w/the 2026 Joseph Simone Quality Care Award at the upcoming #ASCOQLTY26! Read about her journey & finding purpose in every aspect of cancer care: bit.ly/4ypiCh1

021

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 28/09/2026

Announcing the ASCO Quality Care Symposium Featured Voices! Follow them before, during, and after the meeting for expert insights. Join the conversation w/ the official hashtag #ASCOQLTY26. Registration is open: bit.ly/4hOQAEH

021

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 19/08/2026

The best care is collaborative. 🤝 Don’t miss your chance to join the premier community dedicated to elevating the patient experience. Secure your spot at #ASCOQLTY26 in Boston and save with early bird rates by August 26: bit.ly/4c3z6Cc

012

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 10/07/2026

Among patients with advanced #BiliaryTractCancer, durvalumab plus gemcitabine and cisplatin provided sustained 4-year overall survival benefit and a comparable safety profile vs placebo plus chemotherapy ja.ma/4ygxazN

RCT: Durvalumab + Chemo for advanced biliary tract cancer. 685 participants (median age 64) were randomized. Findings show Durvalumab + GemCis (341) significantly improved OS vs. Placebo + GemCis (344). HR 0.75. Graph shows survival curves.

011

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 10/07/2026

The draft guideline recommendations for "Integration of Patient-Reported Outcomes in the Routine Care of Adults Undergoing Systemic Treatment for Cancer" are now available. Help us refine these standards of care. Submit your feedback to us by July 22: bit.ly/4h3Xkzx

042

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 16/06/2026

🚨 @ascocancer.bsky.social #ASCOQLTY26 provides an unparalleled opportunity to present data-driven science to help educate the oncology community & elevate care for all. It's the LAST DAY to share your work & contribute to the conversation on patient-centered outcomes. 👉 www.asco.org/quality

asco.org

ASCO Quality Care Symposium - ASCO

032

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 09/06/2026

Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. ☕ Grab your Dunks & submit an abstract by June 16 at 11:59 PM (ET): bit.ly/49NsXsK

041

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 06/06/2026

Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/3S1igN7

Kaplan-Meier survival curves show overall survival for EOCRC patients with/without treatment delay across 4 graphs: general, localized, regional, metastatic. Treatment delay consistently leads to lower survival (P<.001-.047) over 72 months. Y-axis: Overall survival %.

031

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 31/05/2026

Older adults with advanced cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/3RwiJH5

JAMA Oncology: Brief Report on Outcomes of Older Adults with Advanced Cancer preferring Quality of Life vs Prolonging Survival, a secondary analysis of the GAP70+ Clinical Trial. Authors: Richardson, Wang, Flannery et al. Published March 5, 2026.

121

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 02/06/2026

Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar: 🚨Abstracts are due in 2 weeks 6/16/2026 📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026 See you in Boston! www.asco.org/quality

A woman with glasses and a mask in front of a large sign advertising ASCO ACS with the dates 10/16-10/17

064

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 21/05/2026

Adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improved overall survival for #GastricCancer with peritoneal metastasis, with safety profiles comparable to intravenous-only therapy. ja.ma/3PA3fAX

Kaplan-Meier estimates of survival. Top graph shows overall survival, with IP median @number and PS median @number. Bottom graph shows progression-free survival, IP median @number and PS median @number. X axis: Months since randomization.

011

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Network Open @jamanetworkopen.com · 17/05/2026

Rural counties had stable or increased #LiverCancer (#HCC) incidence and mortality rates from 2001 to 2022, while urban counties experienced decreases, highlighting persistent rural-urban disparities. ja.ma/4nvw0ve

Two line graphs compare age-adjusted incidence rates per 100,000 for men and women from 2001 to 2022. Urban and rural county data are shown. The men's graph has urban rates (dark teal) starting higher, peaking around 2010, then declining. "Urban 2001-2008@1", "Urban 2008-2022@2", "Rural 2001-2007@3", "Rural 2007-2022@4". The women's graph shows lower rates and less variance overall. "Urban 2001-2009@5", "Urban 2009-2022@6", "Rural 2001-2022@7".

021

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 12/05/2026

Recommend a colleague by June 5, 2026, for the upcoming ASCO Election. Learn more and submit your recommendations: bit.ly/4cKmkYI

011

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 22/04/2026

Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care. Prepare your submission: bit.ly/4cF0WUW

042

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 09/03/2026

Older adults with advanced #cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/4bf65m0

Forest plot showing association between patient preference for survival/quality of life and clinical outcomes. Outcomes listed with Hazard Ratio (HR) and 95% Confidence Interval (CI). Outcomes include: Treatment modifications@0, Hospitalizations@1, Grade 3 to 5 TRAEs@2, Death at 6 mo@3, Death at 12 mo@4.

012

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · 07/03/2026

Dr @lpetrillz.bsky.social accepts the #EarlyCareer Investigator award here at @aahpm.bsky.social's #hapc26 for her innovative and revolutionary work in #pallonc and #survonc. Well deserved!! 👏 @realbowtiedoc.bsky.social @darcyburbage.bsky.social @ascocancer.bsky.social @crisbergerot.bsky.social

1105

Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 06/03/2026

Outcomes of Older Adults With Advanced #Cancer Who Prefer Quality of Life vs Prolonging Survival: A Secondary Analysis of the GAP70+ Cluster Randomized Clinical Trial. jamanetwork.com/journals/jam... @jama.com @jamaoncology.com #GeriOnc #SuppOnc @mycarg.bsky.social

020

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA @jama.com · 27/01/2026

Analysis of US mortality data indicates breast cancer, lung cancer, and leukemia deaths decreased in people younger than 50, while #ColorectalCancer mortality rose to become the leading cancer death by 2023. ja.ma/4qN1RII

JAMA Research Letter: Leading Cancer Deaths in People Younger Than 50 Years. Four graphs show temporal changes in cancer-related deaths in the US from 1990-2023. Data is broken down by overall deaths, age-adjusted death rate, males, and females.

044

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA @jama.com · 30/12/2025

Among #Medicare Advantage beneficiaries aged 75 years or older with #cancer, a lay health worker–administered telephone assessment reduced acute care use, including 68% lower odds of hospitalization, compared with standard care. ja.ma/4plhA05

Infographic titled JAMA: Lay Health Worker-Led Intervention. It studies if a lay health worker-led symptom assessment intervention reduces acute care among older adults with cancer. The infographic has details about population, intervention, findings, and location.

093

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA @jama.com · 30/12/2025

💬 Editorial: A randomized trial in community oncology clinics demonstrated that telephone-based lay health worker–administered PRO assessments for older adults with #cancer resulted in reductions in acute care utilization and lower mortality. ja.ma/4ax5ygt

JAMA cover: 'A Scalable Model to Improve Cancer Care for Older Adults—Lo-Fi, High Impact' by Alexi A. Wright et al. Published online Dec 30, 2025. Editorial highlights cancer care disparities in older adults.

172

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 26/12/2025

Among over 7000 patients with #cancer, higher baseline fatigue before systemic therapy was linked to an increased risk of severe, life-threatening, and fatal adverse events. ja.ma/4qmZtrt

Graph titled 'Odds Ratios (ORs) by Adverse Event (AE) and Baseline Fatigue Level' shows fatigue amount versus OR (log scale) for Grades 3-5. Grade 5 fatigue increases with fatigue amount. Grade 3-5 has slight increase with fatigue amount.

031

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 23/10/2025

Great session! Thank you @ryannipp.bsky.social ! Mark your calendars for #ASCOQuality in Boston on 10/16-10/17/2026!

022

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 21/10/2025

Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect @ryannipp.bsky.social DM for the link or to be added to our mailing list. @realbowtiedoc.bsky.social @crisbergerot.bsky.social @ericroeland.bsky.social @fionnualacrowley.bsky.social #pallonc

1125

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 11/10/2025

💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them! @fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social

0124

Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 10/10/2025

Great to hear an expert discussion on #FinancialToxicity from Dr. Jeffrey Peppercorn at #ASCOQLTY25 this afternoon! meetings.asco.org/2025-asco-qu... @ascocancer.bsky.social #PallOnc #SuppOnc #CancerResearch

172

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 10/10/2025

I am honored to give the #ASCOQLTY25 Simone Award to @drrobinyabroff.bsky.social today. Dr Yabroff has a profound impact as a researcher, policy advocate, & mentor. It's hard to find someone in health services research that hasn't been positively influenced by her intellect, wit, & warmth.🏆

ASCO
JOSEPH SIMONE
QUALITY CARE AWARD
Robin Yabroff, PhD, MBA, FASCO
American Cancer Society

082

Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 10/10/2025

Excellent first session this morning at #ASCO Quality Care Symposium: “Partners in Care: Building Bridges Through Shared Decisions.” meetings.asco.org/meetings/202... #ASCOQLTY25 #CancerCare #CancerResearch @ascocancer.bsky.social

031

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 06/10/2025

The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research. 📖 Review abstracts today! ✈️ Join us this weekend in Chicago meetings.asco.org/abstracts-pr...

#ASCOQLTY25
Abstracts Now
Available
Explore more than 600 abstracts spanning the entire spectrum of health services research from distinguished leaders in quality care.
View Abstracts

052

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 24/09/2025

🚨 #ASCOQLTY25 Registration Alert‼️ (before rates go up this Friday)! 🗣️ Engage in meaningful discussions 🤝 Build lasting relationships 🔋 Leave feeling energized & inspired ➡️ Join us in Chicago Oct 10-11, 2025 @ascocancer.bsky.social www.asco.org/quality/registration-hotels/registration-details

Two news articles:

2025 ASCO Quality Care Symposium
QUALITY
Sharing Decision-Making, Providing Cancer Care During Catastrophes, and More:
Sessions to Attend at the 2025 ASCO Quality Care Symposium
September 4, 2025
The 2025 ASCO Quality Care Symposium (QCS) will take place on October 10 and 11 and focus on the theme of "Driving Solutions, Implementing Change." The Symposium includes sessions on shared decision-making, cancer care during catastrophic events, palliative care, research funding, and new research.
QUALITY
Dr. Robin Yabroff Presented With Joseph Simone Quality Care Award
September 4, 2025
Robin Yabroff, PhD, MBA, FASCO, of the American Cancer Society, is the 2025 recipient of the Joseph Simone Quality Care Award and Lecture. The award recognizes extraordinary individuals who have made multiple, significant, and enduring contributions to the quality and safety

0104

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Cris Bergerot, PhD @crisbergerot.bsky.social · 04/09/2025

Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social

091

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 02/09/2025

We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS

097

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 31/08/2025

Despite high insurance coverage rates, individuals diagnosed with #cancer in Massachusetts experienced increases in medical debt, with those having bladder and colorectal cancer facing additional increases. ja.ma/4p1IivY

Four plots comparing financial outcomes for cancer patients and control individuals across time. The plots show trends in mean total debt, debt in collections, medical debt in collections, and credit score relative to cancer diagnosis.

021

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Cris Bergerot, PhD @crisbergerot.bsky.social · 28/08/2025

Our study tested GAIN-S in older adults w metastatic cancer 🇧🇷 ➡️ GAIN-S improved emotional + adaptive aspects of prognostic awareness vs usual care Full paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/... Thanks to #WilliamDale #EnriqueSoto @paulobergerot.bsky.social @ryannipp.bsky.social

011

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 25/08/2025

⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon! Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery. 📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)

asco.org

Registration Details - ASCO

Early Registration Deadline: Wednesday, September 3, 2025 at 11:59 PM (ET)

086

Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 11/08/2025

Clinical trial-related financial considerations from Deep South-patients with breast #cancer who previously declined trial participation. link.springer.com/article/10.1... @cancercaremascc.bsky.social #FinancialToxicity #BreastCancer #CancerResearch @grocquemd.bsky.social @cphilwil.bsky.social

251

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 04/08/2025

Gather with peers and friends who share your dedication to addressing quality, safety, and efficiency in #CancerCare delivery and join us in Chicago, October 10-11, for #ASCOQLTY25. Early registration closes on Sept. 3. Reserve your space today: brnw.ch/21wUEIk

055

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

JAMA Oncology @jamaoncology.com · 23/07/2025

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4f5YdVl

021

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Cris Bergerot, PhD @crisbergerot.bsky.social · 13/06/2025

📢 Just published in JNCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer @ryannipp.bsky.social jnccn.org/view/journal...

011

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 10/06/2025

🚨 @oncoalert.bsky.social Deadline Alert TODAY‼️ #ASCOQLTY25 Abstracts are due tonight! Engage in meaningful discussions, build lasting relationships, & leave feeling energized & inspired; join us in Chicago Oct 10-11, 2025. 👉 asco.org/quality @ascocancer.bsky.social

ASCO Quality
Care Symposium
October 10-11, 2025 | Chicago, IL & Online | #ASCOQLTY25
Addressing Quality, Safety, and
#ASCOQLTY2S
Efficiency in Cancer Care Delivery

043

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 09/06/2025

🚨Deadline Alert TOMORROW‼️ 📅 Tuesday, June 10 #ASCOQLTY25 @ascocancer.bsky.social Abstract submissions are due this week! Share your solutions-driven research & help shape the future of quality cancer care. Don’t miss the premier forum for innovation in care delivery! 👉 asco.org/quality

ASCO Quality Care Symposium
DRIVING SOLUTIONS, IMPLEMENTING CHANGE
October 10-11, 2025 • Marriott Marquis
Chicago • Chicago, IL & Online
Abstract Submissions
Close 6/10
Showcase your work for advancing quality cancer care. Contribute your solutions-oriented research to the 2025 ASCO Quality Care Symposium-the premier meeting addressing the quality, safety, and efficiency in cancer care delivery.
SUBMIT NOW →
MENU
#ASCOQLTY25

061

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 09/06/2025

This #ASCOEdBook paper discusses the advances in targeted therapies & immunotherapies to treat #PancreaticCancer & cautions that clinical trials should answer questions that matter to patients. Learn more: brnw.ch/21wTgZn

041

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 06/06/2025

Connect with us near the Chicago lakefront this autumn to delve into the latest, data-driven, interdisciplinary cancer science aimed at improving the lives of people living with cancer everywhere. Register today for #ASCOQLTY25: brnw.ch/21wTdvO

052

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Melissa (Kah Poh) Loh, MD, MS, FACCC, FASCO @melissaloh.bsky.social · 31/05/2025

Always grateful for the #gerionc community that we have and it feels like we have all grown up #fasco #asco25 @mycarg.bsky.social @wilmotcancer.bsky.social @msedrak.bsky.social @ryannipp.bsky.social

041

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 01/06/2025

Amazing being introduced as #FASCO with my incredible @ascocancer.bsky.social Leadership Development Program friends at #ASCO25. 🙌 Drs Mina Sedrak and @ryannipp.bsky.social

There people standing close, each wearing a fasco tie or scarf

0162

Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 31/05/2025

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. ascopubs.org/doi/full/10.... @ascocancer.bsky.social #ASCO25 #PallOnc #CancerResearch

040

Reposted by Ryan Nipp, MD, MPH, MBA, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 30/05/2025

‼️ #ASCO25 simultaneous publication by Jacobs et al:  BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...

044

Ryan Nipp, MD, MPH, MBA, FASCO @ryannipp.bsky.social · 24/05/2025

Cancer Surveillance in the United States in Jeopardy: Leveraging 21st Century Technology to Enhance Public Health. ascopubs.org/doi/full/10.... @ascocancer.bsky.social @americancancersoc.bsky.social #CancerResearch #CancerCare #Healthcare #MedTech @drrobinyabroff.bsky.social

050